Trial
NCT04956276
Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
Warm Autoimmune Hemolytic Anemia
Intervention
ALXN1830
Why stopped
Sponsor decision to terminate program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-11